RESMED INC — Director's Dealing 2022

Nov 22, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2022-11-21

Reporting Person: BLAISE LUCILE (President, Sleep & RC Business)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-21	ResMed Common Stock	F	114	$224.40	Disposed	6705	Direct
2022-11-21	ResMed Common Stock	F	78	$224.40	Disposed	6627	Direct
2022-11-21	ResMed Common Stock	F	75	$224.40	Disposed	6552	Direct

Footnotes

F1: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/21/2019.

F2: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2020.

F3: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/18/2021.